Overview

First-In-Human Study To Evaluate The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Escalating Single And Multiple Doses Of CSL040 In Healthy Subjects

Status:
Recruiting
Trial end date:
2025-03-01
Target enrollment:
Participant gender:
Summary
First-In-Human Study To Evaluate The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Escalating Single And Multiple Doses Of CSL040 In Healthy Subjects
Phase:
Phase 1
Details
Lead Sponsor:
CSL Behring